Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
Descriptor ID |
D015212
|
MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 | 1997 | 2 | 1 | 3 | 1999 | 1 | 1 | 2 | 2000 | 0 | 2 | 2 | 2002 | 0 | 2 | 2 | 2003 | 0 | 2 | 2 | 2004 | 3 | 2 | 5 | 2005 | 2 | 0 | 2 | 2006 | 2 | 1 | 3 | 2007 | 4 | 1 | 5 | 2008 | 3 | 1 | 4 | 2009 | 0 | 1 | 1 | 2010 | 4 | 0 | 4 | 2011 | 4 | 3 | 7 | 2012 | 4 | 2 | 6 | 2013 | 10 | 2 | 12 | 2014 | 8 | 1 | 9 | 2015 | 7 | 1 | 8 | 2016 | 7 | 7 | 14 | 2017 | 16 | 2 | 18 | 2018 | 16 | 3 | 19 | 2019 | 10 | 2 | 12 | 2020 | 11 | 2 | 13 | 2021 | 20 | 1 | 21 | 2022 | 19 | 1 | 20 | 2023 | 20 | 0 | 20 | 2024 | 10 | 4 | 14 | 2025 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
Yu Z, Swift KA, Hedges MA, Theiss AL, Andres SF. Microscopic messengers: Extracellular vesicles shaping gastrointestinal health and disease. Physiol Rep. 2025 Apr; 13(7):e70292.
-
Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Falloon K, Dossaji Z, Mude P, Abushamma S, Ananthakrishnan A, Barnes EL, Bhalla J, Bhattacharya A, Cheemalavagu S, Colombel JF, Cross RK, Ermann J, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kline TM, Kuhn KA, Long MD, Loftus EV, Lukin DJ, Patel A, Rubin DT, Scherl EJ, Shah SA, Siaton BC, Sleiman J, Qazi T, Weisman MH, Cohen BL, Feagan BG, Rieder F. Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review. Inflamm Bowel Dis. 2025 Mar 03; 31(3):812-842.
-
Santangelo BE, Bada M, Hunter LE, Lozupone C. Hypothesizing mechanistic links between microbes and disease using knowledge graphs. Sci Rep. 2025 Feb 26; 15(1):6905.
-
Ermann J, Hong SJ, Stahly A, Dalal RS, Malik F, Scott FI, Click B, Way A, Davis JM, Shmais M, Raffals LE, Jan R, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland JE, Patel S, Kuhn KA, Weisman MH. Frequency of Spondyloarthritis Symptoms Among US Patients With Inflammatory Bowel Disease: A Cross-Sectional Multi-Center Study. Arthritis Care Res (Hoboken). 2025 Jun; 77(6):777-784.
-
Thomas T, Friedrich M, Rich-Griffin C, Pohin M, Agarwal D, Pakpoor J, Lee C, Tandon R, Rendek A, Aschenbrenner D, Jainarayanan A, Voda A, Siu JHY, Sanches-Peres R, Nee E, Sathananthan D, Kotliar D, Todd P, Kiourlappou M, Gartner L, Ilott N, Issa F, Hester J, Turner J, Nayar S, Mackerodt J, Zhang F, Jonsson A, Brenner M, Raychaudhuri S, Kulicke R, Ramsdell D, Stransky N, Pagliarini R, Bielecki P, Spies N, Marsden B, Taylor S, Wagner A, Klenerman P, Walsh A, Coles M, Jostins-Dean L, Powrie FM, Filer A, Travis S, Uhlig HH, Dendrou CA, Buckley CD. A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease. Nat Immunol. 2024 Nov; 25(11):2152-2165.
-
Saeedi BJ, Carr HE, Higgins PDR, Steiner CA. AXL: A novel therapeutic target in IBD. Adv Pharmacol. 2024; 101:141-157.
-
Honan AM, Jacobsen GE, Drum H, Vazquez EN, Quintero MA, Deshpande AR, Sussman DA, Kerman DH, Damas OM, Proksell S, Van der Jeught K, Abreu MT, Chen Z. Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation State. Clin Transl Gastroenterol. 2024 Sep 01; 15(9):e1.
-
Ioannou S, Beecham A, Gomez L, Dauer R, Khakoo N, Pascual L, Quintero M, Lopez J, Leavitt JS, Solis N, Ortega M, Deshpande AR, Kerman DH, Proksell S, Torres EA, Haritunians T, Li D, Abreu MT, McGovern DPB, McCauley JL, Damas OM. Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2025 May; 23(6):1008-1018.e7.
-
Click B, Cross RK, Regueiro M, Keefer L. The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care. Clin Gastroenterol Hepatol. 2025 Feb; 23(3):419-427.e3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|